|
Adult and Pediatric Brain Tumors: Current Concepts and Controversies
Co-Chairpersons: Luis F. Parada, UT Southwestern Medical Center, Dallas, TX; and Susan Chang, University of California, San Francisco, CA
- Gabriele Bergers, University of California, San Francisco, CA
- Antonio Iavarone, Columbia University, New York, NY
- Luis F. Parada
- Rosalind A. Segal, Dana-Farber Cancer Institute, Boston, MA
Advancing Targeted Therapy and Immunotherapy in Melanoma
Co-Chairpersons: Levi A. Garraway, Dana-Farber Cancer Institute, Boston, MA; and Lynn Schuchter, Hospital of the University of Pennsylvania, Philadelphia, PA
- Keith Thomas Flaherty, Massachusetts General Hospital, Boston, MA
- Levi A. Garraway
- Georgina Long, University of Sydney, Sydney, Australia
- Antoni Ribas, UCLA Medical Center, Los Angeles, CA
Biology and Therapy of MPN and MDS: Novel Insights From Genetic and Functional Studies
Co-Chairpersons: Catriona H.M. Jamieson, UCSD Moores Cancer Center, La Jolla, CA; and Ross L. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY
- Benjamin Ebert, Brigham and Women's Hospital, Boston, MA
- Sten Eirik Jacobsen, St. Cross College, Oxford, United Kingdom
- Catriona H.M. Jamieson
- Ross L. Levine
Breast Cancer: Basic Science to Target Discovery to Translational and Clinical Research
Co-Chairpersons: Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; and Jos Jonkers, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Carlos L. Arteaga
- René Bernards, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Jos Jonkers
- Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX
The Challenge of Inter- and Intratumoral Heterogeneity in the Management of Ovarian Cancer
Co-Chairpersons: David Huntsman, BC Cancer Agency, Vancouver, BC, Canada; and Stanley B. Kaye, Institute of Cancer Research, Royal Marsden Hospital, Sutton, United Kingdom
- Michael J. Birrer, Massachusetts General Hospital, Boston, MA
- George Coukos, University of Pennsylvania, Philadelphia, PA
- David Huntsman
- Ie-Ming Shih, Johns Hopkins Medical Institutes, Baltimore, MD
Current Concepts in Lung Cancer Research
Co-Chairpersons: Alex A. Adjei, Roswell Park Cancer Institute, Buffalo, NY; and Matthew L. Meyerson, Dana-Farber Cancer Institute, Boston, MA
- Denise R. Aberle, UCLA David Geffen School of Medicine, Los Angeles, CA
- Alex A. Adjei
- Takashi Kohno, National Cancer Center Research Institute, Tokyo, Japan
- Matthew L. Meyerson
Emerging Concepts in Pancreatic Neoplasms
Co-Chairpersons: Dafna Bar-Sagi, New York University School of Medicine, New York, NY; and Diane M. Simeone, University of Michigan, Ann Arbor, MI
- Dafna Bar-Sagi
- Manuel Hidalgo, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
- Sunil R. Hingorani, Fred Hutchinson Cancer Research Center, Seattle, WA
- Diane M. Simeone
Emerging Therapeutic Strategies for Neuroendocrine Cancers
Co-Chairpersons: Herbert Chen, University of Wisconsin, Madison, WI; and Katherine L. Nathanson, University of Pennsylvania School of Medicine, Philadelphia, PA
- Herbert Chen
- Katherine L. Nathanson
- Fiemu E. Nwariaku, UT Southwestern Medical Center, Dallas, TX
- Stanley Sidhu, University of Sydney, Sydney, Australia
The Epigenome/Genome in Colorectal Cancer: From Discovery to Therapeutics
Co-Chairpersons: S. Gail Eckhardt, University of Colorado Cancer Center, Aurora, CO; and Sanford D. Markowitz, Case Western Reserve University, Cleveland, OH
- S. Gail Eckhardt
- Raju Kucherlapati, Harvard Medical School, Boston, MA
- Peter W. Laird, University of Southern California, Los Angeles, CA
- Sanford D. Markowitz
Liver Cancer: Pathogenesis and Treatment
Co-Chairpersons: Josep M. Llovet, Icahn Medical Institute, New York, NY; and Lopa Mishra, The University of Texas MD Anderson Cancer Center, Houston, TX
- Gregory J. Gores, Mayo Clinic, Rochester, MN
- Markus Grompe, Oregon Health and Science University, Portland, OR
- Josep M. Llovet
- Lopa Mishra
Mechanisms of Hereditary Cancer: Beyond the Tumor Suppressor Paradigm
Co-Chairpersons: Charis Eng, The Cleveland Clinic, Cleveland, OH; and David Malkin, University of Toronto Hospital for Sick Children, Toronto, ON, Canada
- Steven E. Artandi, Stanford University School of Medicine, Stanford, CA
- Charis Eng
- William D. Foulkes, McGill University, Montreal General Hospital, Montreal, QC, Canada
- David Malkin
New and Old Targets as Prognostic and Therapeutic Biomarkers in Head and Neck Cancer
Co-Chairpersons: Jennifer Rubin Grandis, University of Pittsburgh School of Medicine, Pittsburgh, PA; and Robert L. Ferris, University of Pittsburgh Cancer Institute, Pittsburgh, PA
- Ruud H. Brakenhoff, VU University Medical Center, Amsterdam, The Netherlands
- Barbara A. Burtness, Fox Chase Cancer Center, Philadelphia, PA
- Robert L. Ferris
- Jeffrey N. Myers, The University of Texas MD Anderson Cancer Center, Houston, TX
New Concepts in the Pathogenesis and Targeted Treatment to Multiple Myeloma
Chairperson: Jonathan D. Licht, Northwestern University Lurie Comprehensive Cancer Center, Chicago, IL
- Faith Davies, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom
- Ola Landgren, National Cancer Institute, Bethesda, MD
- Jonathan D. Licht
- Constantine Sideris Mitsiades, Dana-Farber Cancer Institute, Boston, MA
New Therapeutic Strategies in B-Cell Lymphoma and Leukemia Using Genomics and Signaling Inhibitors
Co-Chairpersons: Kerry Savage, BC Cancer Agency, Vancouver, BC, Canada; and Louis M. Staudt, National Cancer Institute, Bethesda, MD
- John C. Byrd, Ohio State University Comprehensive Cancer Center, Columbus, OH
- Elias Campo, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain
- Kerry Savage
- Louis M. Staudt
The Next Generation of Therapeutic Targets for Advanced Prostate Cancer
Co-Chairpersons: Gerhardt Attard, Institute of Cancer Research, Sutton, United Kingdom; and Arul M. Chinnaiyan, University of Michigan, Ann Arbor, MI
- Gerhardt Attard
- Brett S. Carver, Memorial Sloan-Kettering Cancer Center, New York, NY
- Karen E. Knudsen, Thomas Jefferson University Kimmel Cancer Center, Philadelphia, PA
- Mark A. Rubin, Weill Cornell Medical College of Cornell University, New York, NY
Sarcomas: Leading New Strategies for Delineating Mechanisms, Genes, and Treatments in Rare Cancers
Co-Chairpersons: Rama Khokha, University of Toronto, Toronto, ON, Canada; and Robert G. Maki, Memorial Sloan-Kettering Cancer Center, New York, NY
- Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
- Katherine A. Janeway, Dana-Farber Cancer Institute, Boston, MA
- Rama Khokha
- Robert G. Maki
Thyroid Cancer Induced by Radiation: Epidemiology, Clinical Features, and Molecular Pathways
Co-Chairpersons: Yuri E. Nikiforov, University of Pittsburgh School of Medicine, Pittsburgh, PA; and Elizabeth Cardis, Centre for Research in Environmental Epidemiology, Barcelona, Spain
- Vladimir Drozdovitch, National Cancer Institute, Bethesda, MD
- Elizabeth Cardis
- Yuri E. Nikiforov
- Arthur B. Schneider, University of Illinois at Chicago, Chicago, IL
Translational Advances in Mesothelioma: Predisposition, Progression, Therapeutics
Co-Chairpersons: Hedy Lee Kindler, University of Chicago Medical Center, Chicago, IL; and Jonathan A. Fletcher, Brigham and Women’s Hospital, Boston, MA
- Dean Fennell, Belfast City Hospital, Belfast, Ireland
- Hedy Lee Kindler
- Marc Ladanyi, Memorial Sloan-Kettering Cancer Center, New York, NY
- Joseph R. Testa, Fox Chase Cancer Center, Philadelphia, PA
|